{"version":"1.0","provider_name":"Actualidad CEU","provider_url":"https:\/\/medios.uchceu.es\/actualidad-ceu","author_name":"Teresa Soriano","author_url":"https:\/\/medios.uchceu.es\/actualidad-ceu\/author\/tsoriano\/","title":"Les enjeux de la pharmacovigilance en oncologie","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"eDFvkrpCaB\"><a href=\"https:\/\/medios.uchceu.es\/actualidad-ceu\/les-enjeux-de-la-pharmacovigilance-en-oncologie\/\">Les enjeux de la pharmacovigilance en oncologie<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/medios.uchceu.es\/actualidad-ceu\/les-enjeux-de-la-pharmacovigilance-en-oncologie\/embed\/#?secret=eDFvkrpCaB\" width=\"600\" height=\"338\" title=\"\u00abLes enjeux de la pharmacovigilance en oncologie\u00bb \u2014 Actualidad CEU\" data-secret=\"eDFvkrpCaB\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/medios.uchceu.es\/actualidad-ceu\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/medios.uchceu.es\/actualidad-ceu\/wp-content\/uploads\/sites\/2\/2021\/02\/IMG_4724-scaled.jpg","thumbnail_width":2560,"thumbnail_height":1707,"description":"Les traitements sp\u00e9cifiques pour chaque patient, avec des dosages personnalis\u00e9s, font l\u2019actualit\u00e9 dans la recherche contre le cancer, selon Vanesa Escudero, chercheuse de l\u2019Universit\u00e9 CEU UCH \u00e0 Elche. Gr\u00e2ce \u00e0 la pharmacovigilance en oncologie, on pourra ajuster les doses et identifier un pourcentage \u00e9lev\u00e9 de patients, chez qui, a priori, les sch\u00e9mas posologiques standards conduiraient [&hellip;]"}